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Pro‑angiogenic scaffold‑free 
Bio three‑dimensional conduit 
developed from human induced 
pluripotent stem cell‑derived 
mesenchymal stem cells promotes 
peripheral nerve regeneration
Sadaki Mitsuzawa1,7, Chengzhu Zhao2,7, Ryosuke Ikeguchi1*, Tomoki Aoyama3, 
Daisuke Kamiya2,4, Maki Ando1, Hisataka Takeuchi1, Shizuka Akieda5, Koichi Nakayama6, 
Shuichi Matsuda1 & Makoto Ikeya2,4*
Although autologous nerve grafting is widely accepted as the gold standard treatment for segmental 
nerve defects, harvesting autologous nerves is highly invasive and leads to functional loss of the 
ablated part. In response, artificial nerve conduits made of artificial materials have been reported, 
but the efficacy of the nerve regeneration still needs improvement. The purpose of this study is to 
investigate the efficacy and mechanism of the Bio three‑dimensional (3D) conduit composed of xeno‑
free human induced pluripotent stem cell–derived mesenchymal stem cells (iMSCs). The 5‑mm nerve 
gap of the sciatic nerve in immunodeficient rats was bridged with the Bio 3D conduit or silicone tube. 
Functional and histological recovery were assessed at 8 weeks after surgery. The regenerated nerve 
in the Bio 3D group was significantly superior to that in the silicone group based on morphology, 
kinematics, electrophysiology, and wet muscle weight. Gene expression analyses demonstrated 
neurotrophic and angiogenic factors. Macroscopic observation revealed neovascularization both 
inside and on the surface of the Bio 3D conduit. Upon their subcutaneous implantation, iMSCs could 
induce angiogenesis. The Bio 3D conduit fabricated from iMSCs are an effective strategy for nerve 
regeneration in animal model. This technology will be useful in future clinical situations.
Peripheral nerve injury is often accompanied by trauma or tumor resection. The gold standard treatment when 
tensionless direct repair cannot be achieved is autologous nerve  grafting1,2. Unlike solid organ transplantation 
such as heart, liver, kidney, or lung, a grafted nerve does not function itself, but offers the best scaffold for axonal 
 elongation3. It does, however, have several potential disadvantages, including donor site morbidity, limited sup-
ply, risk of neuroma formation, mismatch of the caliber diameter, necessity of an extra surgical incision, and 
increased operative  time4. A nerve allograft resolves some of these disadvantages, but requires perioperative 
immunosuppression and a particular preservation  method5. Because peripheral nerve injury causes merely 
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non-life threatening sensory and motor disturbance, the appropriateness of systemic immunosuppression therapy 
remains controversial.
An artificial nerve conduit represents a third option and is already used in selected clinical  settings6. As the 
development of tissue engineering progresses, several studies have reported well-devised nerve conduits with 
improvements in the supportive cells, scaffolds, growth factors, and  vascularity7,8. However, most of these con-
duits consist of artificial materials and are faced with the inevitable problems of low biocompatibility, foreign 
body reactions, and risk of infection.
To address these potential problems, we focused on novel technology of the Bio three-dimensional (3D) 
computer-controlled  printing9. Nerve conduits created by Bio 3D printers are scaffold-free tubular tissues, com-
posed entirely of homogenous multicellular spheroids without synthetic materials. Our previous study confirmed 
the efficacy of the Bio 3D conduit in peripheral nerve  regeneration10,11. This concept of the Bio 3D conduit differs 
completely from others previously reported, and was considered to be a major breakthrough in the field of nerve 
regeneration. Originally, among all of the other cell types, primary dermal fibroblasts derived from adults were 
chosen to fabricate the spheroids for the Bio 3D conduits, because of their accessibility, proliferation, structural 
strength, and support for Schwann  cells10,12. However, the quality of the fibroblasts depends on the donor’s state 
of health and is not easily stabilized, factors that could be major hurdles for off-the-shelf products.
Recent progress in induced pluripotent stem cell (iPSC)-based technology could provide a  solution13. We 
have established a robust and simple protocol to induce mesenchymal stromal/stem cells (MSCs) from iPSCs 
through neural crest cell (NCC) lineage (iMSCs, hereafter)14. This stepwise induction protocol makes it possible 
to control and evaluate the quality and quantity of iMSCs. Moreover, compared to fibroblasts, MSCs are able to 
differentiate into a broad spectrum of end-stage cells, secrete a wide variety of immunomodulatory molecules, 
assemble exosomes, and repair damaged tissue via a mitochondrial transfer  mechanism15,16. However, MSCs 
derived from bone marrow, adipose tissue, placenta, umbilical cord or other connective tissues have limita-
tions, including accessibility, limited supply, invasive procedures, limited expandability and less differentiation 
potential during long-term culture. The quality of these MSCs also shows wide variation among donors. All of 
these problems could be resolved by iMSCs. iPSCs can ultimately be  expanded17, and NCCs and iMSCs can be 
expanded over 10  passages14,18. Additionally, NCCs and iMSCs can be stored as frozen stocks. These character-
istics offer great advantages for future clinical applications because, once NCCs were expanded and stored, over 
 1010 iMSCs could be obtained reproducibly from the same NCC stock, which will make it easier to check and 
control their quality. A neuroprotective effect of iMSCs is expected since peripheral glial cells are derived from 
NCCs. Further, NCC-derived endoneurial mesenchymal precursor cells have been shown to contribute to tissue 
repair and  regeneration19, suggesting their regenerative potential for damaged tissues.
Thus, the purpose of the present study is to evaluate the Bio 3D conduit composed of human iMSCs in 
peripheral nerve regeneration in a rat sciatic nerve defect model. Our results indicate that the engrafted iMSCs 
accelerate nerve regeneration in terms of supportive cells, growth factors, and especially vascularity.
Results
Generating the Bio 3D conduit. In the following experiments, we used iMSCs induced from human 
iPSCs (hiPSCs) of a neural crest lineage under xeno-free conditions (see “Materials and methods”). iMSCs were 
cultured on temperature-responsive plates to generate cell sheets, and the cell sheets were then transferred to low-
adhesion plates to generated clumps of iMSCs (C-iMSCs) (Fig. 1A,B)20. C-iMSCs with diameters of 500 ± 50 µm 
were arranged into a 9 × 9 needle array of a Bio-3D printer according to a pre-designed computer mode and 
then cultured with perfusion until adjacent C-iMSCs fused together. The fused conduits were then transferred 
onto a catheter and further cultured until the nerve conduit achieved a sufficient degree of strength. H&E and 
anti-human vimentin staining demonstrated the existence of iMSCs and the surrounding self-produced ECM 
complex in C-iMSCs and the Bio 3D conduits (Fig. 1C).
To investigate the properties of cells constituting nerve conduits, global gene expression profiles at each Bio 
3D conduit-generating step were analyzed. Principal component analysis (PCA) and a heatmap of pluripotent 
stem cell (PSC), NCC, and MSC gene expressions revealed that the gene expression patterns of iMSCs, cell 
sheets, C-iMSCs, and the Bio 3D conduits were similar to bone marrow mesenchymal stem cells (BM-MSCs), 
and distinct of iPSC and iPSC-derived NCCs (iNCCs) (Fig. 2A,B). Additionally, the MSC markers such as CD44, 
CD73, CD90, and CD105 were normally expressed at each step (Fig. 2B,C). The successful induction of iMSCs 
was also confirmed by showing the characteristics of surface markers for MSC (positive for CD73, CD105, and 
CD44, and negative for CD45 and HLA-DR) (Fig. 2D).
Transplantation and macroscopic observation of the Bio 3D conduit. All the Bio 3D conduits met 
the five criteria for the desired function and strength (retaining luminal structure, being easily graspable with 
forceps, having elastic force, being suitable for needle insertion, and being able to tolerate suturing), which is 
described in our previous  study11. To examine the effect of the Bio 3D conduit, transplantation to the rat sciatic 
nerve defect model was performed (Fig. 3A-a,b). Eight weeks after the transplantation surgery, macroscopic 
observation was performed to check the morphology of the conduit and their effect on circumferential tissue 
(Fig. 3A-c,d). In both the Bio 3D conduit and silicone tube groups, the nerve gap was successfully bridged in 
all rats. In terms of degradation, the Bio 3D conduit maintained its shape macroscopically. Intriguingly, neo-
vascularization was markedly observed at the superficial layer of the Bio 3D conduit (Fig. 3B-a,b). Transverse 
and longitudinal sections in the Bio 3D conduit showed a regenerated nerve at the center of the Bio 3D conduit, 
and neovascularization around the regenerated nerve inside the Bio 3D conduit (Fig. 3B-c–e, and yellow dotted 
circle in Fig. 3B-f). In contrast, in the silicone group, only a very thin regenerated nerve was observed in the 
silicone tube (Fig. 3A-d).
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Functional recovery of the regenerated nerve. To examine the functional recovery of the Bio 3D 
group, several evaluations were performed.
The pinprick test was performed to evaluate sensory recovery. Eight weeks after surgery, all rats in the Bio 
3D group were scored as grade 3 (Fig. 4A). In the silicone group, one rat was scored as grade 3 and five rats 
were scored as grade 2. Although both groups showed functional recovery for the sensory nerve, there was a 
significant difference between the two groups (P < 0.01), indicating the Bio 3D group exhibited more functional 
recovery of the sensory nerve.
The toe-spread test was performed to evaluate motor recovery. Eight weeks after the surgery, in the Bio 3D 
group, five rats were scored as grade 3 and one rat was scored as grade 2 (Fig. 4B). In the silicone group, one 
rat was scored as grade 2, three rats were scored as grade 1, and two rats were scored as grade 0. There was a 
significant difference between the two groups (P < 0.01), indicating the Bio 3D group exhibited more functional 
recovery of the motor nerve.
To evaluate behavioral functional recovery, the kinematic properties of the hind limbs were measured while 
the rat was walking on a treadmill. The mean drag toe (DT) was 0.0 ± 0.0 in the Bio 3D group and 0.13 ± 0.15 
in the silicone group (Fig. 4C). There was no significant difference between the two groups. The Bio 3D group 
showed a significantly greater angle of attack (AoA) (− 28.70° ± 6.08°) than the silicone group (− 70.72° ± 7.49°) 
Figure 1.  Generation of the Bio 3D conduit from xeno-free iMSCs. (A) Experimental design for the Bio 3D 
conduit. iMSCs are cultured on a temperature-responsive plate to generate a cell sheet. The cell sheets are then 
transferred to a low attachment plate to generate clumps of the iMSC/ECM complex, C-iMSCs. C-iMSCs are 
arranged into a needle array to generate the Bio 3D conduits and transplanted into a model rat. Eight weeks 
later, the recovery of the nerve injury was analyzed. (B) Images of cell sheets, C-iMSCs, pre-designed computer 
models, and Bio 3D structures in the Bio 3D conduit-generating step. After 1 week of perfusion, C-iMSCs are 
fused together and transferred to the catheter. Because the structures are shortened on the catheter, two conduits 
are fused together to achieve sufficient length. Scale bars: Cell sheet and C-iMSC, 500 µm; 3D structure and 
Bio-3D conduit, 2 mm. (C) Section images of C-iMSCs and the Bio 3D conduit. Staining with H&E (left) or 
anti-hVimentin (green, middle) and anti-Collagen1 (Col1) (red, right). Nuclei were stained with DAPI (blue). 
Scale bars, 500 µm.
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(P < 0.01) (Fig. 4D). According to Tajino et al., the AoA of the intact nerve group and the non-treatment (just 
dissected) group were approximately − 1° and − 47°,  respectively21. The silicone group in this study showed 
worse function than the non-treatment group in the literature, which is because the follow up time of 8 weeks 
aggravated the function of the extensor digitorum muscle to extend the toes until the regenerated nerve bridged 
between the stumps. Although the Bio 3D group in this study showed improved function for walking behavior 
compared to the silicone group, it is still inferior to the intact nerve in the previous study.
To confirm that the newly elongated axon will reach the neuromuscular junction of the target muscle, we 
performed an electrophysiological study of the pedal adductor muscle. The Bio 3D group exhibited a significantly 
greater amplitude than the silicone group (19.07 ± 7.88% vs. 3.15 ± 0.66%, respectively; P < 0.05) (Fig. 4E). The 
mean motor nerve conduction velocity (MNCV) was higher in the Bio 3D group than in the silicone group 
(58.52 ± 12.96% vs. 39.23 ± 17.77%, respectively), although the difference was not significant (Fig. 4F). These 
data indicated that the target muscle was more strongly re-innervated in the Bio 3D group. According to Zhang 
et al., the amplitude values of the nerve autograft group, the Bio 3D (human-gingiva derived MSCs) group, and 
the silicone group were approximately 65%, 52%, and 28%,  respectively22. Although our results were not as good 
as in their report, the different study protocol (rat facial nerve, 5-mm gap, 12 weeks follow up) might explain 
this. Once a nerve has begun to regenerate through the Bio 3D conduit (human iMSCs), increasing compound 
muscle action potentials (CMAPs) can be expected over time.
To check for muscle atrophy caused by peripheral nerve injury, the wet muscle weight of the tibialis anterior 
muscle was measured. The wet muscle weight was significantly heavier in the Bio 3D group than the silicone 
group (58.77 ± 4.44% vs. 31.65 ± 4.87%, respectively; P < 0.01) (Fig. 4G), indicating target muscle atrophy in the 
silicone group was greater than in the Bio 3D group. According to Santiago et al. and Sowa et al. (rat sciatic nerve, 
5- or 6-mm gap, 12 weeks follow up), the wet muscle weights of the gastrocnemius muscle in the nerve auto-
graft group, the collagen tube group, and the non-treatment group were 66.6%, approximately 40%, and 19.2%, 
 respectively23,24. In the non-treatment group, no regeneration was observed between proximal and distal nerve 
stumps. Because the wet muscle weight of the tibialis anterior muscle in the current silicone group was 31.65%, 
we can compare the Bio 3D group (58.77%) to those in previous studies above to some extent. Little muscle 
atrophy in the Bio 3D group suggested that the target muscle was re-innervated from the early stage of recovery.
Figure 2.  Cells composing the Bio 3D conduit maintained MSC properties. (A) Global gene expression profile. 
PCA analysis indicates no obvious change in the cell character in each Bio 3D conduit-generating step. (B) 
Heatmap illustrating the expression of pluripotent stem cell (PSC), neural crest cell (NCC), and mesenchymal 
stem cell (MSC) markers for cells in each Bio 3D conduit-generating step. (C) The mRNA expression of MSC 
marker genes was confirmed by RT-qPCR. MSC marker genes were expressed normally, indicating the MSC 
character was maintained. *P < 0.05, **P < 0.01 by Dunnett’s multiple comparisons t test compared with iPSCs. 
(D) iMSCs expressed surface markers for MSCs (CD44, CD90, CD90 and CD105), and were negative for CD45 
and HLA-DR.
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Figure 3.  Transplantation of the Bio 3D conduit and macroscopic observation 8 weeks after surgery. (A) An 
8-mm Bio 3D conduit (a) or silicone tube (b) was interposed into the sciatic nerve defect. The proximal and 
distal nerve stumps were pulled 1.5 mm into the conduit to create a 5-mm interstump gap. (c) Regenerated 
nerve 8 weeks after surgery. The engrafted Bio 3D conduit was not yet degraded, and its diameter remained 
larger than the proximal and distal stumps. (d) In the silicone group, although the nerve gap was successfully 
bridged, the regenerated nerve was very thin in the silicone tube. (B) Macroscopic observation of the harvested 
Bio 3D conduit 8 weeks after surgery. (a) Outer surface of the Bio 3D conduit shows newly formed blood vessels 
outside the conduit. An extended image of the white line box is shown as (b). (c) Longitudinally cut surface of 
the Bio 3D conduit shows newly formed blood vessels inside the conduit. An extended image of the white box 
is shown as (d). (e) A transversely cut surface revealed the newly formed blood vessels inside the conduit. An 
extended image of the white box is shown as (f). (f) A regenerated nerve at the center of the Bio 3D conduit 
(yellow dotted circle), and neovascularization around the regenerated nerve were confirmed. Scale bars: (a, c, e) 
5 mm, (b, d, f) 1 mm.
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Figure 4.  Functional recovery 8 weeks after surgery. (A) The pinprick test was performed to evaluate sensory recovery. All 
rats in the Bio 3D group were scored as grade 3. In the silicone group, one rat was scored as grade 3 and five rats were scored 
as grade 2. Although both groups showed functional recovery for the sensory nerve, there was a significant difference between 
the two groups (P < 0.01). (B) The toe-spread test was performed to evaluate motor recovery. In the Bio 3D group, five rats 
were scored as grade 3 and one rat was scored as grade 2. In the silicone group, one rat was scored as grade 2, three rats were 
scored as grade 1, and two rats were scored as grade 0. There was a significant difference between the two groups (P < 0.01). 
The Bio 3D group exhibited more functional recovery for the motor nerve. (C, D) Kinematic analysis showed that no drag 
toe (DT) was observed in the Bio 3D group. The Bio 3D group showed a significantly greater angle of attack (AoA) compared 
to the silicone group (*P < 0.01). (E, F) Electrophysiological study revealed significantly higher amplitude in the Bio 3D 
group (**P < 0.05). Motor nerve conduction velocity (MNCV) tended to be faster in the Bio 3D group, however, there was no 
significant difference between the two groups. (G) Wet muscle weight (WMW) of the tibialis anterior muscle. Little muscle 
atrophy was observed in the Bio 3D group with significance (*P < 0.01).
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Histological examination of the regenerated nerve. To evaluate the quantity and quality of the 
regenerated nerve, histological and morphometric analyses were performed.
Semi-thin toluidine blue staining of the mid-portion in the Bio 3D group exhibited many well myeli-
nated axons (Fig. 5A-a,c,e) compared to the silicone group (Fig. 5A-b,d,f). The Bio 3D group showed a sig-
nificantly larger myelinated axon number (14,837 ± 4,094) than the silicone group (5,824 ± 1,255) (P < 0.01) 
(Fig. 5B). Transmission electron microscopy (TEM) revealed myelinated axons with proper myelin sheaths 
existed in the Bio 3D group. The Bio 3D group also showed a significantly larger myelinated axon diameter 
(4.241 ± 0.502 μm) compared to the silicone group (2.064 ± 0.173 μm) (P < 0.01) and significantly thicker myelin 
formation (0.861 ± 0.114 μm vs. 0.367 ± 0.036 μm) (P < 0.01). Finally, the G ratio of the Bio 3D group was sig-
nificantly smaller (0.591 ± 0.017) than the silicone group (0.640 ± 0.020) (P < 0.01). Overall, the morphology of 
the regenerated axons was demonstrated to be superior to those in the silicone group. According to Yurie et al. 
and Yamamoto et al., the total number of myelinated axons of the intact nerve group, the nerve autograft group, 
the Bio 3D (human fibroblast) group, and the collagen conduit group were 11,351, 14,345, 6,516, and 5,417, 
 respectively10,25. Because of the short follow up time of 5 weeks in the study design of Yamamoto et al., the larger 
number for the nerve autograft group might indicate axonal sprouting from the proximal nerve stump. The Bio 
3D (human iMSCs) group in the current study also demonstrated a similar result. As to the quality of the newly 
Figure 5.  Histological and morphometric evaluation of the regenerated nerve. (A) (a–d) Semi-thin 
transverse sections (toluidine blue staining) under light microscopy. (e, f) Ultra-thin transverse sections under 
transmission electron microscopy. The mid-portion of the Bio 3D group exhibited an obviously larger cross-
sectional area than the silicone group did. The regenerated nerve of the Bio 3D group also exhibited many well 
myelinated axons. Scale bars: (a, b) 1,000 μm, (c, d) 50 μm, (e, f) 2 μm. (B) The Bio 3D group showed greater 
myelinated axon number, larger axon diameter, and thicker myelin formation. The G ratio of the Bio 3D group 
was smaller than that of the silicone group. All data showed significant differences between the two groups 
(P < 0.01).
8Vol:.(1234567890)
Scientific RepoRtS |        (2020) 10:12034  | https://doi.org/10.1038/s41598-020-68745-1
www.nature.com/scientificreports/
elongated axons, Yurie et al. reported that the myelinated axon diameter/myelin thickness values of the intact 
nerve group were 4.122 μm/1.112 μm, and those of the Bio 3D (human fibroblast) group were 2.189 μm/0.623 μm. 
The regenerated nerves of the Bio 3D (human iMSCs) group in this study and the intact nerve group in the pre-
vious study were very alike in terms of axonal quality. In summary, the regenerated nerve through the current 
Bio 3D conduit (human iMSCs) was superior in terms of both the quantity and quality of the myelinated axons.
Pro‑neurogenic and pro‑angiogenic potential of the Bio 3D conduit. The benefits of iMSCs on 
tissue regeneration have been associated with the ability to produce a broad variety of cytokines and paracrine 
 factors20. Therefore, we evaluated whether the Bio 3D conduit expressed pro-neurogenic and pro-angiogenic 
factors. Global gene expression profiles revealed iMSCs in each Bio 3D conduit-generating step including a 
large subset of upregulated neurogenesis and angiogenesis related genes in the Gene Ontology (GO) categories 
(Fig. 6A, Table S2).
RT-qPCR confirmed similar patterns of representative neurogenesis (NGF, NRG1, TRAF6 and HGF)- and 
angiogenesis (VEGFA, VEGFB, ANGPT1, and ANGPT2)-related gene expressions (Fig. 6B). These data suggest 
that the Bio 3D conduits (pre-transplantation) have the potential to support nerve regeneration through their 
pro-neurogenic and pro-angiogenic capability.
Angiogenetic potential of iMSCs. Since pro-angiogenic factors were expressed in the Bio 3D conduit and 
abundant neovascularization around the Bio 3D conduit was observed macroscopically (Fig. 3B), the angioge-
netic property of iMSCs was tested by transplanting iMSCs under the rat dorsal skin soaked with an atelocollagen 
sponge (Pelnac; Gunze, Kyoto, Japan). Gross photos under an operative microscope at 2 weeks after transplanta-
tion are shown in Fig. 7A. The total area of angiogenesis of the iMSC group was 3.12 ± 0.27 mm2, which tended 
to be larger than that of the Pelnac group (2.59 ± 0.33 mm2) and was significantly larger than that of the silicone 
group (1.50 ± 0.51 mm2, P < 0.01) (Fig. 7B). Consistently, the total length of angiogenesis of the iMSC group was 
29.45 ± 5.05 mm, which was significantly longer than that of the Pelnac group (21.15 ± 4.70 mm, P < 0.05) and the 
silicone group (19.27 ± 4.08 mm, P < 0.01) (Fig. 7C). Finally, the number of closed networks of angiogenesis of the 
iMSC group was 16.17 ± 2.19, which was significantly larger than that of the Pelnac group (10.17 ± 2.97, P < 0.01) 
and the silicone group (6.50 ± 2.99, P < 0.01) (Fig. 7D). These results revealed that subcutaneously transplanted 
iMSCs induce newly formed vessels more strongly than Pelnac alone as the control group (the Pelnac group).
Discussion
The present study demonstrated the efficacy and mechanism of the Bio 3D conduit developed from iMSCs on 
peripheral nerve regeneration. Although the effectiveness of the Bio 3D conduit for peripheral nerve regenera-
tion was confirmed in previous reports in the case of  fibroblasts10,11 and of gingiva-derived  MSCs22, the present 
study is novel in that we used iPSC-derived MSCs for the first time. The cell type is a key issue of the regenerative 
medicine for future clinical application of neurological disorders.
Several studies have reported that the essential components for nerve regeneration include  scaffolds26,27, 
 vascularity28–30 supportive  cells23,25, and growth  factors31,32. In terms of scaffolds, the Bio 3D conduit in the present 
study was composed of pure biological tissues fabricated from homogenous cells. Eliminating synthetic materials 
diminishes the risk of foreign-body reactions, infections, and allergies. Although the Bio 3D conduit does not 
offer the same microstructure as a scaffold, its wall is sufficiently thick and substantial to retain its lumen, hold 
anchoring sutures, and resist surrounding scar formation. From the standpoint of vascularity, preinserted vessels 
inside artificial nerve conduits promote capillary formation and are useful for nerve  regeneration28–30. The Bio 
3D conduit in this study adopted a different method from that above. iMSCs should acquire additional viability 
through perfusion cultivation before transplantation and induce larger amounts of circumferential blood supply 
in the living body compared to artificial nerve conduits. In the present study, the engrafted Bio 3D conduit was 
less likely to become necrotic or degrade 8 weeks after surgery based on macroscopic observation. We investigated 
newly formed blood vessels macroscopically both at the superficial and deep layers of the Bio 3D conduit and 
found the new vessels to have mainly originated from blood vessels accompanying the original sciatic nerve stumps 
(Fig. 3B). An angiogenesis assay confirmed the capacity of iMSCs to induce neovascularity, which is consistent 
with the VEGF expression in the Bio 3D conduit. From the perspective of supportive cells, MSCs and other cell 
types transplanted into the chamber of a conduit have been shown to differentiate into Schwann-like cells and to 
support axonal  elongation24,33,34. However, leakage of the implanted cells from the chamber or the necessity of cell 
migration to artificial material is a matter of issue 35,36. Instead, the Bio 3D conduit in the current study can bear far 
more cells unless it has collapsed, thus its seeding efficacy is obviously superior to that of other methods reported 
so far. In other studies, various growth factors were added to the nerve conduit by direct injection into the lumen 
or other delivery  systems31,32. Due to a loss of quantity through leakage or short-term retention, these efforts are 
often less effective. The Bio 3D conduit could solve these concerns if fabricated from genetically manipulated cells 
to overexpress neurotrophic  factors37. This is a point for improvement in future studies.
Although several Bio 3D printing technologies for tubular constructions have been reported, we chose to 
use the recently developed Kenzan  method9,10,38. Using this novel technology with a simple computer system, 
researchers can freely design the construction in terms of form, diameter, and length. Scaffold-free tubular tissue 
have already been applied to blood vessels and tracheal  cartilage9,39. In the field of peripheral nerve regenera-
tion, the efficacy of the Bio 3D conduit has already been investigated, but there is still room for improvement 
regarding constituent cell  types10,11,22. Looking ahead to future clinical applications, we selected here iMSCs to 
generate Bio 3D conduits.
A previous study confirmed that the newly formed blood vessels within the nerve gap play a key role in pro-
viding Schwann cells with a scaffold for crossing the nerve gap and offering a more conductive environment for 
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axonal  regrowth40. Therefore, vascularity is one of the essential components of nerve regeneration, and macro-
scopic observation in the current study confirmed the formation of newly formed blood vessels both inside and 
outside of the Bio 3D conduit (Fig. 3B). In further detail, there is a marked neovascularization at the superficial 
layer of the Bio 3D conduit. This may be explained by the difference in the blood supply. Namely, blood flow 
of the deep layer of the Bio 3D conduit is served only by the blood vessels that accompany the sciatic nerve. In 
addition to this, the superficial layer of the Bio 3D conduit is supplied with further blood flow by the surrounding 
soft tissue (in this case, the gluteus maximus muscle). Additional experiments also support the capacity of iMSCs 
to induce angiogenesis (Fig. 7). Taken together, utilization of the Bio 3D conduit generated by our method may 
be advantageous for nerve regeneration therapy.
Figure 6.  The Bio 3D conduit promotes neurogenesis and angiogenesis. (A) Heatmap illustrating the 
expression of neurogenesis and angiogenesis related genes in iPSCs, iNCCs, cells in each Bio 3D conduit-
generating step, and BM-MSCs. By convention, highly expressed genes are shown in red and lowly expressed 
genes are shown in blue. iMSCs in each Bio 3D conduit-generating step included a large subset of upregulated 
neurogenesis (left) and angiogenesis (right) related genes. Gene names and values used to obtain the heatmap 
are shown in Table S2. (B) The mRNA expression of neurogenesis and angiogenesis genes was confirmed by 
RT-qPCR. **P < 0.01, by Dunnett’s multiple comparisons t test compared with iPSCs.
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There are several limitations associated with the present study. First, we did not perform a control study 
with a nerve autograft or other commercial synthetic conduit. Because autologous nerve grafting is considered 
the gold standard treatment, further improvements to the efficacy of the Bio 3D conduit are essential before 
comparison. Future research of other cell types to constitute the Bio 3D conduit, co-culture of several types of 
cells to create spheroids, and overexpression of beneficial cytokine with genetic manipulation could help the Bio 
3D conduit catch up with nerve  autografting41. As far as was possible, the Bio 3D conduit in the current study 
was compared to other treatment options from previous studies, including the Bio 3D conduit fabricated from 
other types of cells (human fibroblast or human gingiva-derived MSCs)10,21–25. Second, our experimental design 
involved a fairly small interstump gap of 5 mm, which is not critical in rats and also not long enough to assess 
nerve regeneration. However, this is the first study to use iMSCs to fabricate the Bio 3D conduit, and we regard 
the finding of trustworthy nerve regeneration over a short gap as more important than a less reliable outcome over 
a longer and more challenging gap. Although a longer-length Bio 3D conduit would be time-and-cost consum-
ing and technically demanding, future study should confirm the efficacy of the Bio 3D conduit over longer gaps.
We confirmed that the Bio 3D conduit composed of feeder-free and xeno-free human iMSCs contributes to 
peripheral nerve regeneration. Although further research on safety, effectiveness, and cost should be performed 
before clinical application, the Bio 3D conduit should become a useful alternative to nerve autografts in the 
treatment of nerve defects.
Materials and methods
iMSC culture. Human iPSCs (1231A3) were cultured on an iMatrix-511 (Nippi, Tokyo, Japan)-coated cell 
culture plate in StemFit AK03N (Ajinomoto, Tokyo, Japan) as described  previously42. The xeno-free method 
to induce human iMSCs from human iPSCs is described elsewhere [D. Kamiya, personal communication]. 
Briefly, Cells were cultured in Stemfit Basic03 (Ajinomoto), which is comparable to AK03N minus FGF2, sup-
Figure 7.  Subcutaneous implantation for the angiogenesis assay. (A) Gross photos under an operative 
microscope in three groups. The iMSC group exhibited a greater amount of neovascularization. Scale bars, 
1 mm. (B) The total area of angiogenesis of the iMSC group tended to be larger than that of the Pelnac group 
and was significantly larger than that of the silicone group (*P < 0.01). (C) The total length of angiogenesis of the 
iMSC group was significantly longer than that of the Pelnac group (**P < 0.05) and the silicone group (*P < 0.01). 
(D) The number of closed networks of angiogenesis of the iMSC group was significantly larger than that of the 
other two groups (*P < 0.01).
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plemented with SB431542 (Sigma, St. Louis, MO, USA) and CHIR99021 (Wako, Osaka, Japan), to induce NCCs. 
 CD271+ cells were then sorted by FACS and expanded onto fibronectin-coated plates in Stemfit Basic03 supple-
mented with SB431542, EGF (R&D, Minneapolis, USA), and FGF2. iMSCs were induced and maintained with 
PRIME-XV MSC Expansion XSFM medium (Fujifilm Irvine Scientific, Tokyo, Japan). The cells were diluted at 
a ratio of 1:3 when they reached 70–80% confluence. Cells at passage 3 were used for the experiments. Human 
bone marrow mesenchymal stem cell (hBM-MSC) was obtained from PromoCell (Heidelberg, Germany) and 
cultured in PRIME-XV MSC Expansion XSFM medium.
Preparation of C‑iMSCs. Clumps of an iMSC/extracellular matrix (ECM) complex (C-iMSCs) were pre-
pared as reported previously with minor  modifications20,43. Briefly, iMSCs were seeded at a density of 5 × 104 
cells/well in temperature-responsive 96-well plates (UpCell, CellSeed, Inc., Tokyo, Japan) coated with fibronectin 
and cultured with Prime-XV MSC expansion XSFM for 4 days. To obtain C-iMSCs, confluent cells that had 
formed on the cellular sheet with iMSC-derived ECM were detached from the dishes by switching the culture 
temperature from 37 to 27 °C. The iMSC/ECM complexes were detached from the bottom of the plate in a sheet 
shape, transferred to a 96-well low-cell-adhesion plate (Sumitomo Bakelite, Tokyo, Japan), and rolled up to gen-
erate a round clump of cells. The cell clumps were maintained in Prime-XV MSC expansion XSFM for 5 days.
Preparation of the Bio 3D conduit. To assemble the conduits, C-iMSCs were robotically placed into 
skewers of a 9 × 9 needle array using the “Kenzan method”; C-iMSCs were arranged in a three-dimensional 
shape according to a pre-designed 3D model by the Bio-3D  printer10. The C-iMSCs were then cultured in a 
perfusion bioreactor to promote self-organization of the living cells. Approximately 1 week after 3D printing, 
adjacent C-iMSCs were fused to construct a single tubular shape, removed from the Kenzan array, transferred 
to a perforated 18-gauge intravenous catheter (2 cm) (Surflo; Nipro, Osaka, Japan), and further cultured for 
2 weeks until the desired length (8 mm) and strength was achieved.
Immunocytochemistry. Paraffin-embedded sections were deparaffinized, and antigen retrieval was per-
formed by microwave (300 W, 20 min). Samples were blocked with Blocking One (Nacalai Tesque, Inc.) for 
1 h. DAPI (10 μg/mL) was used to counterstain nuclei. Samples were observed by BZ-9000E (Keyence, Osaka, 
Japan). The antibodies used in this study are summarized in Table S3.
Quantitative PCR analysis. Quantitative PCR analysis was performed as described  previously44. Briefly, 
Total RNA was purified with an RNeasy Kit (Qiagen, Valencia, CA, USA) and treated with a DNase-one Kit 
(Qiagen, MD, USA) to remove genomic DNA. Total RNA (0.1 µg) was reverse transcribed for single-stranded 
cDNA using random hexamers and Superscript III reverse transcriptase (Invitrogen, CA, USA) according to the 
manufacturer’s instructions. Quantitative PCR was performed with the Thunderbird SYBR qPCR Mix (Toyobo, 
Osaka, Japan) and analyzed with the StepOne real-time PCR system (Applied Biosystems, Waltham, MA, USA). 
Primer sequences are listed in Table S1.
Fluorescence‑activated cell sorting. Fluorescence-activated cell sorting (FACS) was performed by Ari-
aII (BD) according to the manufacturer’s protocol. Antibodies used in FACS are listed in Table S3.
Transcriptome analysis. Total RNA was purified using an RNeasy Micro Kit (Qiagen) and treated with the 
DNase-one Kit (Qiagen) to remove genomic DNA. Briefly, 10 ng of total RNA was transcribed to obtain single-
stranded cDNA using the SuperScript VILO cDNA Synthesis Kit (Thermo Fisher Scientific). A cDNA library 
was synthesized using the Ion AmpliSeq Transcriptome Human Gene Expression Core Panel (Thermo Fisher 
Scientific) and Ion Ampliseq Library Kit Plus (Thermo Fisher Scientific) according to the manufacturer’s proto-
col. Barcode-labeled cDNA libraries were analyzed by the Ion S5 XL System (Thermo Fisher Scientific) using the 
Ion 540 Chip Kit (Thermo Fisher Scientific). Total RNA was purified using the RNeasy Micro Kit (Qiagen) and 
treated with the DNase-one Kit (Qiagen) to remove genomic DNA. We reverse transcribed 10 ng of total RNA 
to obtain single-stranded cDNA using the SuperScript VILO cDNA Synthesis Kit (Thermo Fisher Scientific). 
We performed cDNA library synthesis using the Ion AmpliSeq Transcriptome Human Gene Expression Core 
Panel (Thermo Fisher Scientific) and the Ion Ampliseq Library Kit Plus (Thermo Fisher Scientific) according to 
the manufacturer’s protocol. Barcode-labeled cDNA libraries were analyzed by the Ion S5 XL System (Thermo 
Fisher Scientific) using the Ion 540 Chip Kit (Thermo Fisher Scientific).
In vivo experimental design. All animal procedures were performed with approval of and in accord-
ance with guidelines of the ethics committee of Kyoto University Graduate School of Medicine, Animal Experi-
mentation Committee. Fifteen adult male F344-rnu/rnu rats with immune deficiency (7-weeks old, weighing 
120–160 g) (Clea, Tokyo, Japan) were used in this study. Rats were randomly divided into Bio 3D (n = 6) and sili-
cone (n = 6) groups for the nerve regeneration study. The remaining three rats were prepared for the additional 
experiments as part of the angiogenesis assay. Each rat was acclimatized before the surgical procedures, housed 
in a separate cage, and given standard food and water.
Surgical technique. Under general anesthesia, a longitudinal skin incision was made at the posterior thigh 
in the prone position. The right sciatic nerve was exposed through a gluteal muscle splitting approach and 
sharply cut at the middle of the thigh to create a nerve defect. In the Bio 3D group, an 8-mm Bio 3D conduit was 
interposed between the proximal and distal stumps. Under a surgical microscope, each stump was then pulled 
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1.5 mm into the conduit and anchored in place with epineural 9-0 nylon sutures, creating a 5-mm interstump 
gap in the conduit. The wound was closed in layers with 5-0 nylon sutures. In the silicone group, the silicone 
tube (8 mm in length and 2 mm in internal diameter) was interposed in the same procedure. All of the following 
analyses and sample harvesting were performed 8 weeks after surgery.
Pinprick test. A pinching stimulus was applied by means of standardized forceps from the toe to the heel 
until the rat withdrew. Each animal’s response to the pinprick test was graded from 0 to 3 as follows: grade 0, no 
response to stimulus; grade 1, withdrawal response at the heel; grade 2, withdrawal response on the dorsum of 
the foot; grade 3, withdrawal response at the  toes45.
Toe‑spread test. Intact rats extend and abduct their toes when suspended by the base of the tail. The degree 
of toe movement was graded as follows: grade 0, no movement; grade 1, any sign of movement; grade 2, toe 
abduction; grade 3, toe abduction with  extension45.
Kinematic analysis. Before the walking analysis, rats were anesthetized, and six landmarks for each hind 
limb were marked as previously  described10,21,46. Briefly, colored hemispheric plastic markers were bilaterally 
attached onto the shaved skin at five landmarks: the anterior superior iliac spine, hip joint, knee joint, lateral 
malleolus, and fifth metatarsophalangeal joint. To detect the toes, acrylic resin ink was applied to the tip of the 
bilateral middle toe. Hind limb motion was captured at a sampling rate of 120 Hz using a 3D motion capture 
apparatus (Kinema Tracer System; Kissei Comtec, Nagano, Japan) while rats walked at a pace of 10 cm/s. For 
each rat, a total of five or six consecutive steps was included in the following analysis. Markers were traced, 
and 3D displacements were reconstructed by the system. Two parameters were calculated in this study: (1) DT, 
which measures the proportion of the step to the total analyzed step in which the rat’s toe was grounded during 
the swing phase, and (2) AoA, which measures the toe angle to the metatarsal bone at the final segment of the 
swing phase. A smaller DT value represents less limping. A larger AoA value indicates more dorsal flexion in the 
toe just before the rat’s foot is grounded.
Electrophysiological studies. Electrophysiological studies about the sciatic nerve was performed as 
described  previously10,30. Briefly, the bilateral sciatic nerves were exposed at the prone position under general 
anesthesia. The right sciatic nerve was stimulated just distal to the piriformis muscle (S1) and at the popliteal 
fossa (S2) by means of an electromyogram measuring system (Neuropack S1; Nihon Kohden, Tokyo, Japan). 
Two pairs of needle electrodes were inserted into the pedal adductor muscle to check for the CMAPs. The 
amplitude (peak to peak) of the CMAPs evoked with supramaximal electric stimulation from S1 was measured. 
The MNCV was calculated from the distance between S1 and S2. The same procedure was performed on the left 
intact hind limb. The amplitude and MNCV of the CMAPs in the pedal adductor muscle of the right hind limb 
were expressed as a percentage of those in the left hind limb.
Wet muscle weight of the tibialis anterior muscle. After harvesting the regenerated nerve, the bilat-
eral tibialis anterior muscles were exposed and detached from the bone at their origin and insertion, and weighed 
immediately using a digital scale, as described  previously10,30.
Histological and morphometric studies. The regenerated nerve was harvested from six rats in each 
group, fixed in 1% glutaraldehyde and 1.44% paraformaldehyde, post-fixed with 1% osmic acid, and embed-
ded in epoxy resin. Transverse sections (1 μm in thickness) of the mid-portion of the regenerated nerves were 
prepared and stained with 0.5% (w/v) toluidine blue solution and examined by light microscopy (Nikon Eclipse 
80i; Nikon, Tokyo, Japan). Ultra-thin sections of the same tissues stained with uranyl acetate and lead citrate 
were evaluated using TEM (Model H-7000; Hitachi High-Technologies, Tokyo, Japan). Total myelinated axon 
number, the myelinated axon diameter, myelin thickness, and the G-ratio were measured using ImageJ software 
(National Institute of Health, USA) for morphometric analysis as described  previously10,28–30. Briefly, the total 
neural area (a) of each specimen was calculated by choosing six or seven fields at random so that the area ana-
lyzed would represent > 20% of the entire neural area of each specimen. The number of myelinated axons (b), 
neural area (c), shortest diameter of each myelinated axon (d), and axon diameter (e) were calculated for each 
field at a final magnification of 400 ×. The number of myelinated axons and neural areas from all analyzed fields 
were summed. The total number of myelinated axons in each specimen was estimated as b × (a/c). The mean 
myelinated axon diameter was expressed as the average value of the shortest diameter of all myelinated axons, 
the mean myelin thickness was expressed as (d − e)/2, and the G-ratio was expressed as e/d using the mean value 
in the seven fields evaluated.
Subcutaneous implantation for angiogenesis assay. To examine the angiogenesis potential of iMSCs, 
three rats were used to compare the iMSC, Pelnac (Pelnac; Gunze, Kyoto, Japan), and silicone. Under general 
anesthesia, six separate 1-cm transverse incisions at 2-cm intervals were made on the backs of the  rats47,48. In 
the iMSC group, six square atelocollagen sponges (4 × 4 × 2 mm in size, Pelnac) were soaked with 20 μL of com-
plete medium of iMSCs and implanted into each incision under the dorsal skin. In the Pelnac group, six square 
atelocollagen sponges (4 × 4 × 2 mm in size, Pelnac) with 20 μL of complete medium only were implanted. In the 
silicone group, six square silicone sheets (4 × 4 × 2 mm in size) were implanted. Two weeks after the implantation, 
a midline incision on the backs was made to observe newly formed blood vessels on the sponges and silicone 
sheets, and gross photos were taken under an operative microscope. The total area, total length, and the number 
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of closed networks were analyzed using ImageJ software (National Institute of Health, USA) for newly developed 
angiogenesis as described in previous  studies49,50.
Statistical analyses. Data are presented as the means and standard deviations. Data analyses of the pin-
prick test and toe spread test were performed with the Wilcoxon test in JMP (JMP Pro 14.0; SAS Institute, 
Cary, NC, USA). Data analyses of the kinematic analysis, the electrophysiological studies, wet muscle weight 
of the tibialis anterior muscle, and the histological and morphometric studies were performed using Student’s 
t test in Microsoft Excel 2017 (Microsoft, Redmond, WA, USA). Values of P < 0.05 were considered statistically 
significant. Data of the angiogenesis assay were compared using one-way analysis of variance (ANOVA). When 
a significant difference was detected, a post hoc test was applied using the Tukey Kramer test (JMP Pro 14.0). 
Values of P < 0.05 were considered statistically significant.
Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable 
request.
Received: 18 February 2020; Accepted: 26 June 2020
References
 1. Griffin, J. W., Hogan, M. V., Chhabra, B. & Deal, N. Current concept review: peripheral nerve repair and reconstruction. J Bone 
Joint Surg. Am. 95, 2144–2151 (2013).
 2. Dahlin, L. B. Techniques of peripheral nerve repair. Scand. J. Surg. 97, 310–316 (2008).
 3. Tang, P. et al. Histological and functional outcomes of nerve defects treated with acellular allograft versus cabled autograft in a rat 
model. Microsurgery 33, 460–467 (2013).
 4. Battiston, B., Geuna, S., Ferrero, M. & Tos, P. Nerve repair by means of tubulization: literature review and personal clinical experi-
ence comparing biological and synthetic conduits for sensory nerve repair. Microsurgery 25, 258–267 (2005).
 5. Mackinnon, S. E., Doolabh, V. B., Novak, C. B. & Trulock, E. P. Clinical outcome following nerve allograft transplantation. Plast. 
Reconstr. Surg. 107, 1419–1429 (2001).
 6. Konofaos, P. & ver Halen, J. P. Nerve repair by means of tubulization: past, present, future. J. Reconstr. Microsurg. 29, 149–164 
(2013).
 7. Xie, J. et al. Nerve guidance conduits based on double-layered scaffolds of electrospun nanofibers for repairing the peripheral 
nervous system. ACS Appl. Mater. Interfaces 6, 9472–9480 (2014).
 8. Bell, J. H. A. & Haycock, J. W. Next generation nerve guides: materials, fabrication, growth factors, and cell delivery. Tissue Eng. 
Part B 18(2), 116–128 (2012).
 9. Itoh, M. et al. Scaffold-free tubular tissues created by a Bio-3D printer undergo remodeling and endothelialization when implanted 
in rat aortae. PLoS ONE 10(9), e0136681 (2015).
 10. Yurie, H. et al. The efficacy of a scaffold-free Bio 3D conduit developed from human fibroblasts on peripheral nerve regeneration 
in a rat sciatic nerve model. PLoS ONE 12(2), e0171448 (2017).
 11. Mitsuzawa, S. et al. The efficacy of a scaffold-free Bio 3D conduit developed from autologous dermal fibroblasts on peripheral 
nerve regeneration in a canine ulnar nerve injury model: a preclinical proof-of-concept study. Cell Transpl. 28(9–10), 1231–1241 
(2019).
 12. Parrinello, S. et al. EphB signaling directs peripheral nerve regeneration through Sox2-dependent schwann cell sorting. Cell 143, 
145–155 (2010).
 13. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined 
factors. Cell 126, 663–676 (2006).
 14. Fukuta, M. et al. Derivation of mesenchymal stromal cells from pluripotent stem cells through a neural crest lineage using small 
molecule compounds with defined media. PLoS ONE 9(12), e112291 (2014).
 15. Chamberlain, G., Fox, J., Ashton, B. & Middleton, J. Concise review: Mesenchymal stem cells: their phenotype, differentiation 
capacity, immunological features, and potential for homing. Stem Cells 25, 2739–2749 (2007).
 16. Zhao, C. & Ikeya, M. Generation and applications of induced pluripotent stem cell-derived mesenchymal stem cells. Stem Cells 
Int. 2018, 9601623 (2018).
 17. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872 (2007).
 18. Chijimatsu, R. et al. Characterization of mesenchymal stem cell-like cells derived from human iPSCs via neural crest development 
and their application for osteochondral repair. Stem Cells Int. 2017, 1960965 (2017).
 19. Carr, M. J. et al. Mesenchymal precursor cells in adult nerves contribute to mammalian tissue repair and regeneration. Cell Stem 
Cell 24, 240–256 (2019).
 20. Kittaka, M. et al. Clumps of a mesenchymal stromal cell/extracellular matrix complex can be a novel tissue engineering therapy 
for bone regeneration. Cytotherapy 17, 860–873 (2015).
 21. Tajino, J. et al. Three-dimensional motion analysis for comprehensive understanding of gait characteristics after sciatic nerve lesion 
in rodents. Sci. Rep. 8, 13585 (2018).
 22. Zhang, Q. et al. 3D bio-printed scaffold-free nerve constructs with human gingiva-derived mesenchymal stem cells promote rat 
facial nerve regeneration. Sci. Rep. 8, 6634 (2018).
 23. Santiago, L. Y., Alvarez, J. C., Brayfield, C., Rubin, J. P. & Marra, K. G. Delivery of adipose-derived precursor cells for peripheral 
nerve repair. Cell Transpl. 18, 145–158 (2009).
 24. Sowa, Y. et al. Direct conversion of human fibroblasts into schwann cells that facilitate regeneration of injured peripheral nerve 
in vivo. Stem Cells Transl. Med. 6, 1207–1216 (2017).
 25. Yamamoto, T. et al. Trophic effects of dental pulp stem cells on Schwann cells in peripheral nerve regeneration. Cell Transpl. 25, 
183–193 (2016).
 26. Gamez, E. et al. Photofabricated gelatin-based nerve conduits: nerve tissue regeneration potentials. Cell Transpl. 13, 549–564 
(2014).
 27. Hsieh, S. C., Chang, C. J., Cheng, W. T., Tseng, T. C. & Hsu, S. H. Effect of an epineurial-like biohybrid nerve conduit on nerve 
regeneration. Cell Transpl. 25, 559–574 (2016).
 28. Kakinoki, R., Nishijima, N., Ueba, Y., Oka, M. & Yamamuro, T. Relationship between axonal regeneration and vascularity in 
tabulation -an experimental study in rats. Neurosci. Res. 23, 35–45 (1995).
14
Vol:.(1234567890)
Scientific RepoRtS |        (2020) 10:12034  | https://doi.org/10.1038/s41598-020-68745-1
www.nature.com/scientificreports/
 29. Yamakawa, T. et al. Nerve regeneration promoted in a tube with vascularity containing bone marrow-derived cells. Cell Transpl. 
16, 811–822 (2007).
 30. Kaizawa, Y. et al. A nerve conduit containing a vascular bundle and implanted with bone marrow stromal cells and decellularized 
allogenic nerve matrix. Cell Transpl. 26, 215–228 (2017).
 31. Gordon, T. The role of neurotrophic factors in nerve regeneration. Neurosurg. Focus 26(2), E3 (2009).
 32. Lee, A. C. et al. Controlled release of nerve growth factor enhances sciatic nerve regeneration. Exp. Neurol. 184, 295–303 (2003).
 33. Cui, L. et al. Transplantation of embryonic stem cells improves nerve repair and functional recovery after severe sciatic nerve 
axotomy in rats. Stem Cells 26, 1356–1365 (2008).
 34. Roche, P. et al. Olfactory derived stem cells delivered in a biphasic conduit promote peripheral nerve repair in vivo. Stem Cells 
Translat. Med. 6, 1894–1904 (2017).
 35. Jesuraj, N. J. et al. A systematic evaluation of Schwann cell injection into acellular cold-preserved nerve grafts. J. Neurosci. Methods 
197, 209–215 (2011).
 36. Walsh, S. K. et al. Fate of stem cell transplants in peripheral nerves. Stem Cell Res. 8, 226–238 (2012).
 37. Meyer, C. et al. Peripheral nerve regeneration through hydrogel-enriched chitosan conduits containing engineered Schwann cells 
for drug delivery. Cell Transpl. 25, 159–182 (2016).
 38. Leberfinger, A. N., Ravnic, D. J., Dhawan, A. & Ozbolt, I. T. Concise review: bioprinting of stem cells for transplantable tissue 
fabrication. Stem Cells Transl. Med. 6, 1940–1948 (2017).
 39. Taniguchi, D. et al. Scaffold-free trachea regeneration by tissue engineering with bio-3D printing. Interact. Cardiovasc. Thorac. 
Surg. 26(5), 745–752 (2018).
 40. Cattin, A. L. et al. Macrophage-induced blood vessels guide Schwann cell-mediated regeneration of peripheral nerves. Cell 162, 
1127–1139 (2015).
 41. Song, L. et al. Neural differentiation of spheroids derived from human induced pluripotent stem cells-mesenchymal stem cells 
coculture. Tissue Eng. Part A 24(11–12), 915–929 (2018).
 42. Nakagawa, M. et al. A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells. Sci. 
Rep. 4(1), 3594 (2015).
 43. Yannas, I. V., Tzeranis, D. S., Harley, B. A. & So, P. T. C. Biologically active collagen-based scaffolds: advances in processing and 
characterization. Philos. Trans. R. Soc. A 368, 2123–2139 (2010).
 44. Hino, K. et al. Activin-A enhances mTOR signaling to promote aberrant chondrogenesis in fibrodysplasia ossificans progressiva. 
J. Clin. Investig. 127(9), 3339–3352 (2017).
 45. Siemionow, M. et al. Peripheral nerve defect repair with epineural tubes supported with bone marrow stromal cells. Ann. Plast. 
Surg. 67, 73–84 (2011).
 46. Tajino, J. et al. Intermittent application of hypergravity by centrifugation attenuates disruption of rat gait induced by 2 weeks of 
simulated microgravity. Behav. Brain. Res. 287, 276–284 (2015).
 47. Murashita, T., Nakayama, Y., Hirano, T. & Ohashi, S. Acceleration of granulation tissue ingrowth by hyaluronic acid in artificial 
skin. Br. J. Plast. Surg. 49, 58–63 (1969).
 48. Wang, C. Y. et al. Mesenchymal stem cell-conditioned medium facilitates angiogenesis and fracture healing in diabetic rats. J. 
Tissue Eng. Regen. Med. 6, 559–569 (2012).
 49. Kingham, P. J., Kolar, M. K., Novikova, L. N., Novikov, L. N. & Wiberg, M. Stimulating the neurotrophic and angiogenic properties 
of human adipose-derived stem cells enhances nerve repair. Stem Cells Dev. 23(7), 741–754 (2014).
 50. Kakudo, N. et al. Angiogenic effect of platelet-rich plasma combined with gelatin hydrogel granules injected into murine subcutis. 
J. Tissue Eng. Regen. Med. 11, 1941–1948 (2017).
Acknowledgements
We thank Ms. Keiko Furuta and Mr. Haruyasu Kohda (Division of Electron Microscopic Study, Center for 
Anatomical Studies, Graduate School of Medicine, Kyoto University) for the histological and morphometric 
studies, Dr. Mikihito Kajiya for the C-iMSC generation, Ms. Wako Matsuura for the iMSC culture, Mr. Teppei 
Akeboshi for the RNA sequencing, Dr. Peter Karagiannis for critical reading of the manuscript, and all members 
of the Ikeya and Matsuda laboratories for their support throughout this study. This work was supported by the 
Translational Research program; Strategic PRomotion for practical application of INnovative medical Technology 
(TR-SPRINT) from the Japan Agency for Medical Research and Development (AMED), a grant from AMED 
(#19lm0203053h0002), grants-in-aid for scientific research from the Japan Society for the Promotion of Sci-
ence (JSPS) (#16H05447, #15K10441), the Core Center for iPS Cell Research of the Research Center Network 
for Realization of Regenerative Medicine from the Japan Science and Technology Agency (JST) and AMED, 
the Acceleration Program for Intractable Diseases Research utilizing Disease-Specific iPS cells from AMED, 
the Projects for Technical Development, which is a program of the Research Center Network for Realization of 
Regenerative Medicine, from AMED, a grant from the iPS Cell Research Fund, a grant from Cyfuse Biomedical 
K.K. and a grant from Takeda Pharmaceutical Company Limited.
Author contributions
S.Mi., C.Z., R.I., T.A., S.Ma., and M.I. conceived the research. C.Z. fabricated all the Bio 3D conduits and pre-
pared Figs. 1, 2, 6. S.Mi. designed the study and performed all other experiments. D.K. performed the global 
gene expression analyses. M.A. and H.T. supported interpretation of the data analysis. S.A. and K.N. contributed 
to the generation of the Bio 3D conduit. S.Mi., C.Z., R.I., T.A., and M.I. wrote the manuscript. S.Ma. gave final 
approval of the manuscript.
Competing interests 
Koichi Nakayama is the co-founder and shareholder of Cyfuse Biomedical K.K., Tokyo, Japan (Cyfuse). Shizuka 
Akieda, who are the president of Cyfuse, contributed to the manufacturing of 3D conduits and Cyfuse provided 
the bioprinter to manufacture the conduit. Cyfuse also provided support in the form of a salary for Shizuka 
Akieda and provided research grants to Ryosuke Ikeguchi, Tomoki Aoyama, Koichi Nakayama and Shuichi 
Matsuda. Cyfuse did not have any additional role in the study design, data collection and analysis, decision 
to publish, or preparation of the manuscript. These competing interests do not alter the authors’ adherence to 
Scientific Reports policies on sharing data and materials.
15
Vol.:(0123456789)
Scientific RepoRtS |        (2020) 10:12034  | https://doi.org/10.1038/s41598-020-68745-1
www.nature.com/scientificreports/
Additional information
Supplementary information is available for this paper at https ://doi.org/10.1038/s4159 8-020-68745 -1.
Correspondence and requests for materials should be addressed to R.I. or M.I.
Reprints and permissions information is available at www.nature.com/reprints.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access  This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the 
Creative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not 
permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from 
the copyright holder. To view a copy of this license, visit http://creat iveco mmons .org/licen ses/by/4.0/.
© The Author(s) 2020
